Providing an oncology cell therapy reality check

Challenge

A venture capital investor needed a reality check on a clinical stage cancer biologic prior to a proposed $10m investment.

Solution

We conducted the analysis within four days, which included a review of a comprehensive data room encompassing preclinical, clinical, regulatory, manufacturing and IP matters. Our report identified the areas of key risk in the project and suggested how to mitigate them.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn
Back

Stay in touch